Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patterned photonic array chip based on an intertwined polymer network (IPN) is proposed for the visual detection of glucose. The IPN networks are composed of photonic and poly(acrylic acid) (
PAA
) networks. Aminophenylboronic acid, as a nonenzymatic glucose-responsive moiety that can covalently bond to glucose at alkaline pH, forming tetragonal complexes, is immobilized in the
PAA
network; in hydrogels, this bonding generates Donnan osmotic pressure, resulting in a volumetric increase of the photonic IPN and reflected color change. The photonic band gap wavelength linearly increases with the glucose concentration (in the 1-12 mM range), with a limit of detection of 0.35 mM. The dots of the photonic IPN array respond independently, with high sensitivity and stability, to glucose via color changes; different glucose levels, from hypo- to
hyperglycemia
, can be visually detected in this way. Serum samples spiked with different glucose concentrations were tested for practical evaluation of the chip. The proposed chip could be utilized as a new biosensor platform for cost-effective and easy visual detection in remote areas, without the need of advanced instruments or technology.
...
PMID:Patterned Photonic Array Based on an Intertwined Polymer Network Functionalized with a Nonenzymatic Moiety for the Visual Detection of Glucose. 3154 50